Champions Oncology, Inc. CSBR
4.90
(0.05)
(1.01%)
as of 25 Sep
- Market cap
- $68.9M
- P/E
- 0.0×
Follow CSBR
| Apr '26 | Apr '25 | Apr '24 | Apr '23 | Apr '22 | Apr '21 | Apr '20 | Apr '19 | Apr '18 | Apr '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 20.43 | 0.00 | 0.00 | 190.75 | 414.29 | 0.00 | 908.00 | 0.00 | 0.00 |
P/S ratio |
1.39 | 1.72 | 1.31 | 1.22 | 2.05 | 3.44 | 2.85 | 3.80 | 2.36 | 1.82 |
P/FCF ratio |
0.00 | 13.95 | 0.00 | 59.83 | 24.48 | 0.00 | 133.47 | 100.16 | 0.00 | 0.00 |
P/Operating CF |
(41.26) | 14.22 | (36.18) | (95.11) | 126.50 | (71.20) | 35.92 | 408.60 | 5,300.10 | 70.60 |
P/B ratio |
20.27 | 25.89 | 0.00 | 14.20 | 11.07 | 18.98 | 17.93 | 46.01 | 15,900.31 | 70.25 |
Price to Tangible BV |
22.08 | 28.42 | 0.00 | 15.30 | 11.49 | 19.88 | 19.19 | 65.63 | 0.00 | 0.00 |
EV/Sales |
1.42 | 1.66 | 1.39 | 1.17 | 2.04 | 3.54 | 2.69 | 3.69 | 2.32 | 1.61 |
EV/EBITDA |
355.87 | 15.28 | 0.00 | 0.00 | 44.81 | 93.60 | 0.00 | 113.96 | 0.00 | 0.00 |
EV/Operating CF |
(18.86) | 12.82 | (11.38) | 15.88 | 15.41 | (86.30) | 29.69 | 53.61 | (38.22) | (8.73) |
EV/FCF |
(16.83) | 13.52 | (10.02) | 57.35 | 24.34 | (29.24) | 125.92 | 97.11 | (19.11) | (6.88) |
Quick Ratio |
0.91 | 0.88 | 0.56 | 0.83 | 1.06 | 1.04 | 1.07 | 0.95 | 0.64 | 0.75 |
Current Ratio |
0.96 | 0.94 | 0.63 | 0.90 | 1.13 | 1.13 | 1.10 | 0.99 | 0.68 | 0.79 |
Net Debt/EBITDA |
(20.56) | (1.58) | 0.48 | 0.91 | (0.27) | 2.64 | 6.80 | (3.70) | 0.84 | 0.49 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 21.54% | 23.78% | 31.83% | 15.28% | 0.00% | 0.21% | 0.47% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 1.59 | 0.92 | 1.18 | 0.62 | 0.00 | 5.67 | 0.10 |
Asset Turnover |
2.00 | 1.95 | 1.66 | 1.55 | 1.56 | 1.70 | 2.01 | 2.80 | 2.52 | 2.24 |
Operating CF/Net income |
3.81 | 1.57 | 0.84 | (0.74) | 11.86 | (4.64) | (1.39) | 14.55 | 0.83 | 0.41 |
Capex/Depreciation |
(0.39) | (0.24) | (0.45) | (1.28) | (1.47) | (2.77) | (1.91) | (1.38) | (3.41) | (4.56) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (29.97%) | 503.05% | (532.46%) | (77.70%) | 6.63% | 5.78% | (57.05%) | 11.42% | (732.51%) | (2,157.99%) | |
| (3.96%) | 16.08% | (24.08%) | (15.31%) | 1.74% | 1.50% | (13.07%) | 1.32% | (18.35%) | (99.85%) | |
ROIC |
0.00% | 0.00% | 0.00% | (172.08%) | 4.46% | 1.98% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(41.62%) | 163.23% | 333.61% | (108.66%) | 5.88% | 4.81% | (40.36%) | 5.24% | 476.13% | 1,901.66% |
Average Days of Receivables |
80.94 | 71.82 | 69.32 | 54.28 | 70.70 | 62.13 | 54.20 | 59.02 | 70.63 | 53.86 |
Research and Development Expense of Revenue |
15.29% | 11.99% | 19.03% | 21.43% | 19.09% | 17.53% | 18.22% | 17.73% | 21.74% | 27.86% |
Selling, General and Administrative Expense of Revenue |
34.45% | 29.65% | 36.15% | 32.01% | 31.55% | 29.32% | 33.80% | 28.57% | 32.81% | 53.36% |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.06 | 0.08 | 0.08 |
Share Based Compensation of Revenue |
2.08% | 1.15% | 2.23% | 1.60% | 1.86% | 1.46% | 1.87% | 2.35% | 4.96% | 17.27% |
Graham Net Nets |
(0.04) | (0.06) | (0.22) | (0.16) | (0.07) | (0.05) | (0.02) | (0.01) | (0.06) | (0.06) |
Graham Number |
0.00 | 1.47 | 1.31 | 0.00 | 0.79 | 0.57 | 0.00 | 0.21 | 0.00 | 0.00 |
Earnings Yield |
(1.34%) | 4.90% | (11.13%) | (8.05%) | 0.52% | 0.24% | (2.20%) | 0.11% | (3.15%) | (25.10%) |
Free Cash Flow Yield |
(6.08%) | 7.17% | (10.61%) | 1.67% | 4.08% | (3.52%) | 0.75% | 1.00% | (5.14%) | (12.83%) |
Revenue per Share |
4.30 | 4.17 | 3.70 | 3.98 | 3.72 | 3.12 | 2.71 | 2.39 | 1.84 | 1.44 |
Operating CF per Share |
(0.32) | 0.54 | (0.45) | 0.29 | 0.49 | (0.13) | 0.25 | 0.16 | (0.11) | (0.27) |
Capex per Share |
(0.04) | (0.03) | (0.06) | (0.21) | (0.18) | (0.25) | (0.19) | (0.07) | (0.11) | (0.07) |
Free Cash Flow per Share |
(0.36) | 0.51 | (0.51) | 0.08 | 0.31 | (0.38) | 0.06 | 0.09 | (0.22) | (0.34) |
Cash per Share |
0.35 | 0.72 | 0.19 | 0.75 | 0.68 | 0.36 | 0.70 | 0.29 | 0.08 | 0.31 |
Shareholders Equity per Share |
0.29 | 0.28 | (0.14) | 0.34 | 0.69 | 0.57 | 0.43 | 0.20 | 0.00 | 0.04 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.29 | 0.28 | (0.14) | 0.34 | 0.69 | 0.57 | 0.43 | 0.20 | 0.00 | 0.04 |
Free Cash Flow |
(5.01) | 7.00 | (6.97) | 1.10 | 4.11 | (4.96) | 0.69 | 1.03 | (2.45) | (3.61) |
Working Capital |
(0.70) | (1.49) | (7.90) | (2.28) | 2.19 | 1.43 | 1.19 | (0.10) | (2.39) | (1.58) |
Capital Expenditures |
(0.54) | (0.39) | (0.84) | (2.87) | (2.38) | (3.28) | (2.22) | (0.83) | (1.23) | (0.77) |
Net Current Asset Value |
(3.70) | (6.21) | (14.40) | (10.22) | (6.62) | (7.53) | (2.15) | (1.10) | (3.01) | (1.74) |
EV/EBIT |
0.00 | 20.79 | 0.00 | 0.00 | 164.91 | 396.39 | 0.00 | 369.72 | 0.00 | 0.00 |
Capex to Sales |
0.01 | 0.01 | 0.02 | 0.05 | 0.05 | 0.08 | 0.07 | 0.03 | 0.06 | 0.05 |
Net Profit Margin |
(1.98%) | 8.26% | (14.51%) | (9.90%) | 1.12% | 0.88% | (6.52%) | 0.47% | (7.29%) | (44.67%) |
Price to Operating Income |
0.00 | 21.45 | 0.00 | 0.00 | 165.89 | 385.20 | 0.00 | 381.36 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.39 | 0.37 | 0.33 | 0.31 | 0.23 | 0.19 | 0.29 | 0.24 | 0.17 | 0.14 |
Cash ROIC |
(89.46%) | 22.21% | (1,658.46%) | (14.51%) | (2.40%) | (37.19%) | (6.55%) | (12.49%) | (377.74%) | (108.65%) |
Accounts Receivable Turnover |
4.87 | 5.49 | 5.72 | 6.15 | 5.95 | 6.98 | 7.02 | 6.53 | 6.54 | 8.60 |
Accounts Payable Turnover |
5.54 | 5.65 | 5.28 | 7.20 | 9.93 | 8.52 | 5.72 | 5.75 | 5.27 | 5.18 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
81.54 | 54.62 | 72.00 | 65.93 | 44.30 | 32.23 | 67.42 | 71.82 | 74.50 | 69.67 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
12.19 | 10.37 | 8.77 | 8.76 | 8.25 | 5.88 | 4.57 | 4.15 | 3.10 | 1.79 |
Average Payables |
5.58 | 5.02 | 5.57 | 4.10 | 2.38 | 2.52 | 2.97 | 2.48 | 2.00 | 1.87 |
Average Assets |
29.67 | 29.24 | 30.22 | 34.84 | 31.48 | 24.17 | 16.01 | 9.67 | 8.04 | 6.89 |
Average Common Equity |
3.92 | 0.93 | 1.37 | 6.87 | 8.26 | 6.26 | 3.67 | 1.12 | 0.20 | 0.32 |
Columns are period end dates